๐Talk about financial whiplash! What will go down as biotech history is
$Moderna, Inc.(MRNA)$ . The stock surged an unbelievable 177% yesterday on explosive Phase 3 cancer vaccine validation volume, only to get hit by a savage, profit taking meat grinder today. Moderna plunged 23.55% plus another 2.76% in after hours trading.
Is this explosive wave of Moderna momentum dead or just a temporary setback before it continues its upward momentum?
I find that it is less stressful to just invest in $Health Care Select Sector SPDR Fund(XLV)$ of which Moderna is one of the holdings. The top holdings include $Eli Lilly(LLY)$ $Johnson & Johnson(JNJ)$ $AbbVie(ABBV)$ & $UnitedHealth(UNH)$
For a low expense ratio of just 0.08% ,XLV strips away the heavy fees associated with active thematic trading, making it one of the most cost efficient funds on Wall Street.
XLV also pays a dividend yield of 1.6%.
Investing does not have to be stressful with XLV.
@Tiger_comments @TigerStars
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments